Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic
Crossref DOI link: https://doi.org/10.1007/s13300-017-0323-y
Published Online: 2017-10-23
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kvapil, Milan
Prázný, Martin
Holik, Pavel
Rychna, Karel
Hunt, Barnaby
Funding for this research was provided by:
Novo Nordisk
Text and Data Mining valid from 2017-10-23
Article History
Received: 21 August 2017
First Online: 23 October 2017